Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,524 | 12,504 | 28,962 | 25,850 | 50,945 |
| Marketable Securities | 20,164 | 20,086 | 20,060 | 20,160 | 20,108 |
| Receivables | 50,110 | 49,887 | 51,425 | 43,043 | 44,192 |
| Inventories | 86,532 | 83,414 | 76,453 | 76,228 | 71,732 |
| Income taxes - deferred | N/A | N/A | N/A | 9,193 | 10,013 |
| Other current assets | 2,754 | 2,677 | 7,304 | 2,664 | 2,528 |
| TOTAL | $185,018 | $177,424 | $191,592 | $185,574 | $206,378 |
| Non-Current Assets | |||||
| PPE Net | 28,310 | 23,663 | 19,761 | 68,163 | 70,273 |
| Investments And Advances | 7,850 | 7,664 | 7,108 | 6,049 | 5,717 |
| Intangibles | 84,308 | 84,008 | 78,350 | 83,153 | 86,575 |
| Other Non-Current Assets | 53,527 | 53,209 | 52,921 | 16,670 | 14,562 |
| TOTAL | $173,995 | $168,544 | $158,140 | $174,035 | $177,127 |
| Total Assets | $359,013 | $345,968 | $349,732 | $359,609 | $383,505 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 238 | 269 |
| Accounts payable and accrued liabilities | 48,670 | 41,792 | 43,703 | 36,402 | 44,438 |
| Accrued Expenses | 21,160 | 19,843 | 23,288 | 22,358 | 23,027 |
| Other current liabilities | 15,992 | 14,392 | 16,664 | 11,573 | 9,519 |
| TOTAL | $85,822 | $76,027 | $83,655 | $70,571 | $86,181 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,978 | 2,799 | 1,623 | 1,500 | 1,693 |
| Deferred Revenues | N/A | N/A | N/A | 0 | 8,928 |
| Other Non-Current Liabilities | 1,319 | 1,330 | 1,340 | 2,388 | 2,186 |
| TOTAL | $19,355 | $16,490 | $14,984 | $16,219 | $18,127 |
| Total Liabilities | $105,177 | $92,517 | $98,639 | $86,790 | $104,308 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,910 | 32,839 | 32,838 | 32,787 | 32,690 |
| Common Shares | 329 | 329 | 328 | 328 | 327 |
| Retained earnings | -104,493 | -103,977 | -98,988 | -78,120 | -76,325 |
| Other shareholders' equity | -11,227 | -11,167 | -17,482 | -14,625 | -8,121 |
| TOTAL | $253,836 | $253,451 | $251,093 | $272,819 | $279,197 |
| Total Liabilities And Equity | $359,013 | $345,968 | $349,732 | $359,609 | $383,505 |